Google News – FDA (biotech/pharma) External News
Biotechnology Articles
Google News – Clinical Trials External News
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now? - The Motley Fool
Google News – FDA (biotech/pharma) External News
US FDA approves Ionis Pharma’s therapy to treat rare brain disorder - 1470 & 100.3 WMBD
Google News – FDA (biotech/pharma) External News
US FDA approves Ionis Pharma’s therapy to treat rare brain disorder - whbl.com
Google News – FDA (biotech/pharma) External News
Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder - STAT
Google News – FDA (biotech/pharma) External News
US FDA approves Ionis Pharma's therapy to treat rare brain disorder - Yahoo
Google News – FDA (biotech/pharma) External News
US FDA approves Ionis Pharma's therapy to treat rare brain disorder - tradingview.com
Google News – Clinical Trials External News
Former Pfizer vaccine chief joins Vaxcyte. Trial data is expected by October’s end. - Stock Titan
Google News – CDC External News
Medical groups continue to diverge from CDC on fall vaccine schedule - TechTarget
Google News – FDA (biotech/pharma) External News
Fresenius unit dinged in FDA warning letter flagging 'complaint trend' from customers - Fierce Pharma
Google News – Clinical Trials External News
Psilocybin Prevents Chemotherapy-Related Peripheral Neuropathy in Mice - Genetic Engineering and Biotechnology News
Google News – CDC External News
Slog AM: Gloria Steinem Died, Kids Reject AI Stuffies, and American Health Organizations Are Releasing Their Own Vaccine Recommendations Since the CDC Is Utterly Useless - thestranger.com
Google News – FDA (biotech/pharma) External News
FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod - Fierce Pharma
Google News – CDC External News
With the CDC silent on vaccine guidance, physician-led groups make their own for the upcoming season - Georgia Public Broadcasting
Google News – Biotech Funding External News